Skip to Main Content


News from around Yale and the World

Faculty Network Spotlight: MalarYale

The diverse MalarYale Faculty network aims to integrate studies of the host, parasite, and vector, both within the institution and with our international partners in Burkina Faso, Senegal, Uganda, Cameroon, Peru, and elsewhere.

Read more
  • Spring 2023 Spark Awards

    The Yale Institute for Global Health (YIGH) has selected Laura Forastiere, assistant professor of biostatistics, Edward Miller, associate professor of medicine (cardiovascular medicine), Daniel O’Neil, assistant clinical professor of medicine (medical oncology), Julia Rosenberg, assistant professor, pediatrics (general pediatrics), and Melanie Sion, assistant professor of surgery (general, trauma and surgical critical care) to receive Global Health Spark Awards. Each recipient will receive an award for up to $10,000 and were selected based on their technical merit and long-reaching implications for future global health work.

    Read more
  • Solving global health challenges locally

    In its final Conversation Series for the academic year, the Yale Institute for Global Health invited two distinguished public health officials to share how valuable an international perspective can be for tackling local health disparities.

    Read more
  • ‘The Conflict in Sudan is a Public Health Disaster’

    In Sudan, health systems are under attack while government and paramilitary forces have been battling for control of the country since April 15. As the crisis enters its third week, healthcare professionals in Sudan fear a total collapse of the healthcare system.

    Read more
  • Yale Team Creates Rheumatology Curriculum in Rwanda

    In 2019, Joshua Bilsborrow, MD, MHS, and Rick Bucala, MD, PhD, were awarded a grant from the International League of Associations for Rheumatology (ILAR) to create a rheumatology educational and workshop series for Rwandan internal medicine residents with the goal of increasing rheumatology knowledge among internists and to stimulate interest in pursuing rheumatology training.

    Read more
  • Opinion: Will you need the latest COVID booster? It depends

    The Food and Drug Administration recently amended its authorizations for Pfizer and Moderna’s mRNA vaccines, prompting the Centers for Disease Control and Prevention to modify its COVID-19 vaccine recommendations. Wading through these changes offers a window into our next stage of confronting COVID: adapting as vaccine technology evolves, emphasizing protections for high-risk people and maintaining vaccination as a preventive measure.

    Source: Los Angeles Times
    Read more